MARKETS
Analyst Actions

RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135

Nov 3, 2026 · 10:00 AM ET· updated 9h ago

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $110 to $135.

Share
Why It Matters

An important analyst thinks Hinge Health is doing well and worth more money now. When smart watchers raise their price targets, it often means they see good things ahead.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.